Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential.

Pharmacol Res

National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, China; National Engineering Laboratory for the Development of Southwestern Endangered Medicinal Materials, Guangxi Botanical Garden of Medicinal Plants, Nanning, Guangxi, China. Electronic address:

Published: July 2021

Rheumatoid arthritis is a systemic autoimmune disorder involved in persistent synovial inflammation. Berberine is a nature-derived alkaloid compound with multiple pharmacological activities in different pathologies, including RA. Recent experimental studies have clarified several determinant cellular and molecular targets of BBR in RA, and provided novel evidence supporting the promising therapeutic potential of BBR to combat RA. In this review, we recapitulate the therapeutic potential of BBR and its mechanism of action in ameliorating RA, and discuss the modulation of gut microbiota by BBR during RA. Collectively, BBR might be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2021.105667DOI Listing

Publication Analysis

Top Keywords

therapeutic potential
12
rheumatoid arthritis
8
potential bbr
8
bbr
5
efficacy berberine
4
berberine treatment
4
treatment rheumatoid
4
arthritis multiple
4
multiple targets
4
therapeutic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!